SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000936392-07-000134
Filing Date
2007-02-20
Accepted
2007-02-20 17:04:54
Documents
5
Period of Report
2007-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A a27392e8vkza.htm 8-K/A 21021
2 EXHIBIT 99.1 a27392exv99w1.htm EX-99.1 82217
3 EXHIBIT 99.2 a27392exv99w2.htm EX-99.2 121191
4 EXHIBIT 99.3 a27392exv99w3.htm EX-99.3 88340
5 EXHIBIT 99.4 a27392exv99w4.htm EX-99.4 154330
  Complete submission text file 0000936392-07-000134.txt   468716
Mailing Address
Business Address 11588 SORRENTO VALLEY ROAD SUITE 17 SAN DIEGO CA 92121 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-32335 | Film No.: 07636231
SIC: 2836 Biological Products, (No Diagnostic Substances)